RT Journal Article
SR Electronic
T1 747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A843
OP A843
DO 10.1136/jitc-2023-SITC2023.0747
VO 11
IS Suppl 1
A1 Samhouri, Yazan
A1 Beane, Joal D
A1 Weiss, Sarah
A1 Randolph Hecht, J
A1 Hyngstrom, John
A1 Hanks, Brent A
A1 Ganguly, Bishwa J
A1 Gong, Lucy
A1 Hiraragi, Hajime
A1 Kim, Yeonhee
A1 Nikoo, Navid
A1 Gillenwater, Heidi
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A843.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.